The degree of dysplasia in patients with Barrett’s esophagus (BE) is key to determining the application of BE endoscopic therapy and assigning surveillance intervals. Multiple
low-grade dysplasia
low-grade dysplasia
Artificial Intelligence Detects Dysplasia in Histopathology Slides From Patients With Barrett’s Esophagus
Artificial Intelligence Detects Dysplasia in Histopathology Slides From Patients With Barrett’s Esophagus
Progression in Barrett’s Esophagus Score Can Be Used for Estimating Neoplastic Progression
Progression in Barrett’s Esophagus Score Can Be Used for Estimating Neoplastic Progression
Barrett’s esophagus (BE) is a known precancerous lesion for esophageal dysplasia and adenocarcinoma (EAC); however, it is unclear who will progress to high-grade dysplasia (HGD)
